Answers are grounded in this paper and cite their sources.
Our findings suggest that metabolomic pathways as potential targets for high-risk pancreatic cancer patients.
No takes yet. Share an insight, caveat, or question.
Ghosh et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: